Skip to main content

Get the most out of the BIO Investor Forum by giving a 13-minute Company Presentation to potential partners and investors.

Company Presentations are an integral programming element which allow you to showcase your company's pipeline, R&D activities, and future fundraising goals.

Get in front of an exclusive audience of public and private equity investors and venture capitalists, plus other biotech executives providing valuable exposure to companies poised to grow.

Please note that Companies that are approved to present must pay a Company Presentation fee in addition to being registered to attend the BIO Investor Forum. 

company presenter

Historically, presenters receive double the number of BIO One-on-One™ Partnering meeting requests from investors and potential collaboration partners. Your company will be highlighted in the partnering system, giving you additional visibility as a presenter.

Company Presentation Fees

Registration Fees

registration fees

*All registrants are subject to approval.
**Partnering access is not included/provided with service provider registrations.  To receive this benefit, please contact sponsor@bio.org for sponsorship opportunities.

Registration benefits are subject to change. 

REGISTRATION CLASSIFICATIONS
REGISTRATION POLICIES

For the purposes of registration for any BIO event, conference or meeting, the classification of a registrant as a research and development company, an industry service provider, an academic & technology licensing officer or a qualifying investor is subject to review by BIO.  In its sole discretion, BIO reserves the right to make the determination of the proper classification of a registrant.  Depending on this classification, an additional registration fee may be required. BIO reserves the right to publish materials and restrict conference and/or partnering system access consistent with these determinations.

 


 

Past Presenting Companies

Loading
    • CNS/Neurological
    October 17, 2023 Franciscan D -
    • Tools/Drug Development Support Tech
    October 17, 2023 Franciscan B -
    • Infectious Diseases
    October 18, 2023 Franciscan C -
    • Platform for Therapeutics
    October 17, 2023 Franciscan D -
    • Oncology
    October 17, 2023 Franciscan D -
    • CNS/Neurological
    October 18, 2023 Franciscan B -
    • Oncology
    October 18, 2023 Franciscan C -
    • Infectious Diseases
    October 18, 2023 Franciscan D -
    • Gene/Cell Therapy
    October 18, 2023 Franciscan B -
    • Gene/Cell Therapy
    October 18, 2023 Franciscan B -
    • Oncology
    October 18, 2023 Franciscan C -
    • Diagnostics
    October 17, 2023 Franciscan D -
    • Pain Management
    October 17, 2023 Franciscan D -
    • CNS/Neurological
    October 17, 2023 Franciscan D -
    • Platform for Therapeutics
    October 17, 2023 Franciscan D -
    • Tools/Drug Development Support Tech
    October 17, 2023 Franciscan B -
    • Gene/Cell Therapy
    October 18, 2023 Franciscan B -
    • Infectious Diseases
    October 17, 2023 Franciscan B -
    • Metabolic Diseases
    October 17, 2023 Franciscan B -
    • CNS/Neurological
    October 18, 2023 Franciscan B -
    • Oncology
    October 17, 2023 Franciscan C -
    • Dermatology
    October 17, 2023 Franciscan B -
    • Regenerative Medicine
    October 18, 2023 Franciscan D -
    • Oncology
    October 17, 2023 Franciscan C -
    • Tools/Drug Development Support Tech
    October 17, 2023 Franciscan B -
    • Oncology
    October 17, 2023 Franciscan C -
    • Oncology
    October 17, 2023 Franciscan C -

Best Practices for Delivering a Company Presentation

BIO has worked with Donna LaVoie of LaVoieHealthScience Strategic Communications to develop three best-practice videos to help optimize your Company Presentation at the next BIO event.

VIEW BEST PRACTICES